click enter text
initi peer perform
summari view modest long-term grower averag valuat
tough see out-performance come unless pipelin drug
deliv alreadi expect
full initi slide deck slide link
biotech industri launch deck includ comparison
biotech name exist cover us/eu pharma name see
initi peer perform rate reason grower
long-term still averag rel larg
cap biopharma biotech big pharma name cover organ
financi perform would quit modest otezla
acquisit provid boost given amgn current valuat
middl pack price-to-earnings multipl basi hard see drive
out-performance unless upcom pipelin read-out yield
two tangibl pipelin asset tezepelumab
cancer excit industri begun
crack code elus kra cancer pathway confid
high monotherapi viabl rather combin
therapi like best path forward moment
tezepelumab asthma enter crowd space asthma
biolof captur split econom howev could
deliv dream efficaci regardless eosinophil level per
data btd statu
omecamtiv mecarbil heart failur one wildcard
even approv quit possibl nich size
biosimilar hurt help simultan
collect matur brand biolog product face steadi
biosimilar competit effect seller biosimilar
model latter add increment revenu
trade fundament data
upsid target
report limit sole use client wolf research pleas refer disclosur section locat end
report analyst certif import disclosur disclosur
page
that good hard model biosimilar confid price possibl futur
interchang add risk revenu stream
price target
reli price-to-earnings multipl ep vs peer group averag rang
impli price-to-earnings multipl ep vs peer group averag rang
dcf analysi inform basi price target calcul cover name yield valu
exhibit show incom statement revenu balanc sheet cash flow forecast
page
page
incom statement oper incom expens outstand margin total profit profit profit incom growth oper
page
exhibit wr balanc sheet cash flow statement
page
flow statement incom intang chang oper asset flow oper activ busi net cash acquisit properti flow invest activ lt debt leas treasuri flow financ activ increas decreas cash sheet cash equival st properti plant goodwil current term non-curr comprehens sharehold liabil sharehold
